HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
Charlène MartinSégolène GraciasCharlotte CharpentierDiane DescampsQuentin Le HingratJean-Christophe PlantierElodie Alessandri-GradtPublished in: The Journal of antimicrobial chemotherapy (2021)
This study has shown encouraging results regarding the clinical use of these drugs in HIV-1/non-M-infected patients, which will need to be confirmed with clinical data.